Andrew Horti

Title: Andrew Horti: Innovator in Radiolabeled Compounds

Introduction

Andrew Horti is a notable inventor based in Columbia, MD (US), recognized for his contributions to the field of radiolabeled compounds. He holds 2 patents that focus on innovative methods for imaging nicotinic cholinergic receptors in the brain. His work is significant for both research studies and the diagnosis of neurodegenerative diseases.

Latest Patents

Horti's latest patents include "Radiolabeled pyridyl-7-azabicyclo[2,2,1]heptanes" and "Method for imaging nicotinic acetylcholinergic receptors in the brain." Both inventions are directed towards radiolabeled epibatidine analogues, specifically FPH labeled with radioisotopes of fluorine and/or carbon. These compounds are utilized to noninvasively image and quantify nicotinic cholinergic receptors in the living brain.

Career Highlights

Throughout his career, Andrew Horti has worked with esteemed organizations, including the United States of America as represented by the Department of Health. His contributions have advanced the understanding of brain imaging techniques and their applications in medical research.

Collaborations

Horti has collaborated with notable professionals in his field, including Edythe D London and Alane S Kimes. These partnerships have further enriched his research and development efforts.

Conclusion

Andrew Horti's innovative work in radiolabeled compounds has made a significant impact on the field of neuroscience. His patents are paving the way for advancements in the diagnosis and understanding of neurodegenerative diseases.